Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure

H. Tada, Kensuke Egashira, M. Yamamoto, M. Usui, Y. Arai, Y. Katsuda, H. Shimokawa, A. Takeshita

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The role of endothelium-derived nitric oxide (NO) in the metabolic control of coronary blood flow (CBF) in heart failure (HF) is poorly understood, so the present study investigated the effects of inhibitors of NO synthesis on the response of CBF to changes in myocardial oxygen consumption (MV̇O2) in dogs with HF produced by rapid ventricular pacing and in control dogs. The CBF, MV̇O2, and other hemodynamic parameters were measured in anesthetized animals. Before infusion of Nω-nitro-L-arginine methyl ester (L-NAME), the increases in CBF and MV̇O2 during pacing tachycardia were not significantly different between the control and HF dogs. Intracoronary infusion of L-NAME did not alter the responses of CBF or MV̇O2 to pacing tachycardia in the control dogs, but in the HF dogs, it reduced the CBF response to pacing tachycardia without altering the tachycardia-induced changes in MV̇O2. Intracoronary infusion of L-arginine reversed the effect of L-NAME. These results suggest that in HF dogs NO contributes to the regulation of CBF in response to an increased metabolic demand.

Original languageEnglish
Pages (from-to)827-833
Number of pages7
JournalJAPANESE CIRCULATION JOURNAL
Volume65
Issue number9
DOIs
Publication statusPublished - Sep 26 2001

Fingerprint

Nitric Oxide
Heart Failure
Dogs
Tachycardia
NG-Nitroarginine Methyl Ester
Oxygen Consumption
Arginine
Hemodynamics

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure. / Tada, H.; Egashira, Kensuke; Yamamoto, M.; Usui, M.; Arai, Y.; Katsuda, Y.; Shimokawa, H.; Takeshita, A.

In: JAPANESE CIRCULATION JOURNAL, Vol. 65, No. 9, 26.09.2001, p. 827-833.

Research output: Contribution to journalArticle

Tada, H. ; Egashira, Kensuke ; Yamamoto, M. ; Usui, M. ; Arai, Y. ; Katsuda, Y. ; Shimokawa, H. ; Takeshita, A. / Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure. In: JAPANESE CIRCULATION JOURNAL. 2001 ; Vol. 65, No. 9. pp. 827-833.
@article{6cf4b6bab74944d2bf31e99d21ec93c3,
title = "Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure",
abstract = "The role of endothelium-derived nitric oxide (NO) in the metabolic control of coronary blood flow (CBF) in heart failure (HF) is poorly understood, so the present study investigated the effects of inhibitors of NO synthesis on the response of CBF to changes in myocardial oxygen consumption (MV̇O2) in dogs with HF produced by rapid ventricular pacing and in control dogs. The CBF, MV̇O2, and other hemodynamic parameters were measured in anesthetized animals. Before infusion of Nω-nitro-L-arginine methyl ester (L-NAME), the increases in CBF and MV̇O2 during pacing tachycardia were not significantly different between the control and HF dogs. Intracoronary infusion of L-NAME did not alter the responses of CBF or MV̇O2 to pacing tachycardia in the control dogs, but in the HF dogs, it reduced the CBF response to pacing tachycardia without altering the tachycardia-induced changes in MV̇O2. Intracoronary infusion of L-arginine reversed the effect of L-NAME. These results suggest that in HF dogs NO contributes to the regulation of CBF in response to an increased metabolic demand.",
author = "H. Tada and Kensuke Egashira and M. Yamamoto and M. Usui and Y. Arai and Y. Katsuda and H. Shimokawa and A. Takeshita",
year = "2001",
month = "9",
day = "26",
doi = "10.1253/jcj.65.827",
language = "English",
volume = "65",
pages = "827--833",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "9",

}

TY - JOUR

T1 - Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure

AU - Tada, H.

AU - Egashira, Kensuke

AU - Yamamoto, M.

AU - Usui, M.

AU - Arai, Y.

AU - Katsuda, Y.

AU - Shimokawa, H.

AU - Takeshita, A.

PY - 2001/9/26

Y1 - 2001/9/26

N2 - The role of endothelium-derived nitric oxide (NO) in the metabolic control of coronary blood flow (CBF) in heart failure (HF) is poorly understood, so the present study investigated the effects of inhibitors of NO synthesis on the response of CBF to changes in myocardial oxygen consumption (MV̇O2) in dogs with HF produced by rapid ventricular pacing and in control dogs. The CBF, MV̇O2, and other hemodynamic parameters were measured in anesthetized animals. Before infusion of Nω-nitro-L-arginine methyl ester (L-NAME), the increases in CBF and MV̇O2 during pacing tachycardia were not significantly different between the control and HF dogs. Intracoronary infusion of L-NAME did not alter the responses of CBF or MV̇O2 to pacing tachycardia in the control dogs, but in the HF dogs, it reduced the CBF response to pacing tachycardia without altering the tachycardia-induced changes in MV̇O2. Intracoronary infusion of L-arginine reversed the effect of L-NAME. These results suggest that in HF dogs NO contributes to the regulation of CBF in response to an increased metabolic demand.

AB - The role of endothelium-derived nitric oxide (NO) in the metabolic control of coronary blood flow (CBF) in heart failure (HF) is poorly understood, so the present study investigated the effects of inhibitors of NO synthesis on the response of CBF to changes in myocardial oxygen consumption (MV̇O2) in dogs with HF produced by rapid ventricular pacing and in control dogs. The CBF, MV̇O2, and other hemodynamic parameters were measured in anesthetized animals. Before infusion of Nω-nitro-L-arginine methyl ester (L-NAME), the increases in CBF and MV̇O2 during pacing tachycardia were not significantly different between the control and HF dogs. Intracoronary infusion of L-NAME did not alter the responses of CBF or MV̇O2 to pacing tachycardia in the control dogs, but in the HF dogs, it reduced the CBF response to pacing tachycardia without altering the tachycardia-induced changes in MV̇O2. Intracoronary infusion of L-arginine reversed the effect of L-NAME. These results suggest that in HF dogs NO contributes to the regulation of CBF in response to an increased metabolic demand.

UR - http://www.scopus.com/inward/record.url?scp=0034842518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034842518&partnerID=8YFLogxK

U2 - 10.1253/jcj.65.827

DO - 10.1253/jcj.65.827

M3 - Article

C2 - 11548884

AN - SCOPUS:0034842518

VL - 65

SP - 827

EP - 833

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 9

ER -